"Phosphinic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic or organic derivatives of phosphinic acid, H2PO(OH). They include phosphinates and phosphinic acid esters.
| Descriptor ID |
D010721
|
| MeSH Number(s) |
D01.029.260.700.600 D01.695.625.600 D02.705.629
|
| Concept/Terms |
Phosphinic Acids- Phosphinic Acids
- Acids, Phosphinic
- Hypophosphorous Acids
- Acids, Hypophosphorous
|
Below are MeSH descriptors whose meaning is more general than "Phosphinic Acids".
Below are MeSH descriptors whose meaning is more specific than "Phosphinic Acids".
This graph shows the total number of publications written about "Phosphinic Acids" by people in this website by year, and whether "Phosphinic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphinic Acids" by people in Profiles.
-
Mo H, Hedskog C, Lawitz E, Brainard DM, Yang J, Delaney W, Worth A, Miller MD. Antiviral response and resistance analysis of treatment-na?ve HCV infected patients receiving multiple doses of the NS3 protease inhibitor GS-9256. Antiviral Res. 2017 04; 140:151-157.
-
Yang H, Yang C, Wang Y, Rhodes G, Robinson M, Cheng G, Qi X, Mo H, Tian Y, Pakdaman R, Sheng XC, Kim CU, Delaney WE. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256. Antivir Ther. 2017; 22(5):413-420.
-
Sheng XC, Casarez A, Cai R, Clarke MO, Chen X, Cho A, Delaney WE, Doerffler E, Ji M, Mertzman M, Pakdaman R, Pyun HJ, Rowe T, Wu Q, Xu J, Kim CU. Discovery of GS-9256: a novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity. Bioorg Med Chem Lett. 2012 Feb 01; 22(3):1394-6.
-
Clarke MO, Chen X, Cho A, Delaney WE, Doerffler E, Fardis M, Ji M, Mertzman M, Pakdaman R, Pyun HJ, Rowe T, Yang CY, Sheng XC, Kim CU. Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease. Bioorg Med Chem Lett. 2011 Jun 15; 21(12):3568-72.